https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6595&f=G&l=50&d=PTXT&p=132&S1=20210817&OS=20210817&RS=20210817
Sorrento’s mRNA COVID-19 Vaccine Shows Efficacy In Preclinical Study
Sorrento Therapeutics Inc (NASDAQ:SRNE) has announced preclinical results for its mRNA-based COVID-19 vaccine against SARS-CoV-2. STI-mRNA includes a…